316 related articles for article (PubMed ID: 38668057)
1. Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management.
Criss CR; Makary MS
Curr Oncol; 2024 Apr; 31(4):2076-2091. PubMed ID: 38668057
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine liver metastases: a contemporary review of treatment strategies.
Cloyd JM; Ejaz A; Konda B; Makary MS; Pawlik TM
Hepatobiliary Surg Nutr; 2020 Aug; 9(4):440-451. PubMed ID: 32832495
[TBL] [Abstract][Full Text] [Related]
3. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
[TBL] [Abstract][Full Text] [Related]
4. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
5. Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?
Cavalcoli F; Rausa E; Conte D; Nicolini AF; Massironi S
World J Gastroenterol; 2017 Apr; 23(15):2640-2650. PubMed ID: 28487601
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of pancreatic neuroendocrine liver metastases.
Cloyd JM; Wiseman JT; Pawlik TM
J Gastrointest Oncol; 2020 Jun; 11(3):590-600. PubMed ID: 32655938
[TBL] [Abstract][Full Text] [Related]
7. Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience.
Dhir M; Shrestha R; Steel JL; Marsh JW; Tsung A; Tublin ME; Amesur NB; Orons PD; Santos E; Geller DA
Ann Surg Oncol; 2017 Feb; 24(2):450-459. PubMed ID: 27663565
[TBL] [Abstract][Full Text] [Related]
8. Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.
Zappa M; Abdel-Rehim M; Hentic O; Vullierme MP; Ruszniewski P; Vilgrain V
Target Oncol; 2012 Jun; 7(2):107-16. PubMed ID: 22707276
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
10. The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases.
Ramdhani K; Braat AJAT
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884479
[TBL] [Abstract][Full Text] [Related]
11. Metastatic disease to the liver: Locoregional therapy strategies and outcomes.
Zane KE; Cloyd JM; Mumtaz KS; Wadhwa V; Makary MS
World J Clin Oncol; 2021 Sep; 12(9):725-745. PubMed ID: 34631439
[TBL] [Abstract][Full Text] [Related]
12. The Landmark Series: Neuroendocrine Tumor Liver Metastases.
Gangi A; Howe JR
Ann Surg Oncol; 2020 Sep; 27(9):3270-3280. PubMed ID: 32632880
[TBL] [Abstract][Full Text] [Related]
13. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
Ruszniewski P; O'Toole D
Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
[TBL] [Abstract][Full Text] [Related]
14. Local therapies for hepatic metastases.
Johnston FM; Mavros MN; Herman JM; Pawlik TM
J Natl Compr Canc Netw; 2013 Feb; 11(2):153-60. PubMed ID: 23411382
[TBL] [Abstract][Full Text] [Related]
15. Liver-directed therapies in patients with advanced neuroendocrine tumors.
Jones NB; Shah MH; Bloomston M
J Natl Compr Canc Netw; 2012 Jun; 10(6):765-74. PubMed ID: 22679118
[TBL] [Abstract][Full Text] [Related]
16. Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: A Markov decision model.
Spolverato G; Vitale A; Ejaz A; Kim Y; Cosgrove D; Schlacter T; Geschwind JF; Pawlik TM
Surgery; 2015 Aug; 158(2):339-48. PubMed ID: 25999251
[TBL] [Abstract][Full Text] [Related]
17. A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.
Strosberg JR; Cheema A; Kvols LK
Cancer Control; 2011 Apr; 18(2):127-37. PubMed ID: 21451455
[TBL] [Abstract][Full Text] [Related]
18. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
19. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with hepatic metastases from neuroendocrine tumors.
Clift AK; Frilling A
Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
